TME Pharma Statements
AL
TME Pharma Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
100
—
0
—
0
1.32
0
1.15
0
2.43
0
-2.43
0
-0.9
0
—
0
-3.66
0
—
0
-3.66
0
-1.09
3.37
—
100
—
0
—
0
2.43
0
1.87
0
4.34
0
-4.34
0
-0.4
0
-0.06
0
-4.8
0
0.01
0
-4.8
0
-3.31
1.45
—
100
—
0
—
0
5.71
0
2.01
0
7.66
0
-7.66
0
-2.6
0
-0.06
0
-10.33
0
—
0
-10.33
0
-11.47
0.9
—
100
—
0
—
0
5.75
0
1.75
0
7.56
0
-7.56
0
-0.13
0
—
0
-7.69
0
—
0
-7.69
0
-10.85
0.71
—
100
—
0
—
0
4.91
0
1.13
0
5.89
0
-5.89
0
-0.82
0
-0.05
0
-6.76
0
—
0
-6.76
0
-11.07
0.61
—
100
—
0
—
0
3.08
0
0.89
0
3.86
0
-3.86
0
-0.61
0
-0.02
0
-4.48
0
—
0
-4.48
0
-10.66
0.42
—
100
—
0
—
0
0.94
0
0.99
0
1.89
0
-1.89
0
-3.93
0
-0.1
0
-5.92
0
—
0
-5.92
0
-25.73
0.23
—
100
—
0
—
0
1.05
0
0.88
0
1.92
0
-1.92
0
3.01
0
—
0
1.09
0
—
0
1.09
0
9.08
0.12
—
100
—
0
—
0
1.06
0
1.24
0
2.03
0
-2.03
0
0.08
0
—
0
-1.95
0
—
0
-1.95
0
-19.5
0.1
—
100
—
0
—
0
1.02
0
1.13
0
1.84
0
-1.84
0
-4.84
0
—
0
-6.69
0
—
0
-6.69
0
-111.5
0.06
—
100
—
0
—
0
1.19
0
1
0
2.11
0
-2.11
0
-1.58
0
—
0
-4.05
0
—
0
-4.05
0
-202.5
0.02
—
—
—
1.18
1.31
2.5
-2.5
-0.52
—
-3.02
—
-3.02
-151
0.02
—
—
—
1.22
1.26
2.23
-2.23
0.01
—
-2.23
—
-2.23
-111.5
0.02